Prof Didier Ménard is an expert in Infectiology at Hôpitaux Universitaires de Strasbourg (France). As of October 2026, ScienceLeadR ranks Didier Ménard in the top 1% of experts worldwide for Mosquito-Borne Diseases. Didier Ménard has authored 423 publications, the most recent in 2026, and is an investigator in 8 clinical trials. SLR score: 1,527 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Didier Ménard Hôpitaux Universitaires de Strasbourg France
1 527 ScienceLeadR Reputation 1527
Network Map

Infectiology

Subspecialties: Biochemistry - Hematology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Prof. Didier Ménard is Professor-Hospital Practitioner (PU-PH) at the University of Strasbourg, holder of a Senior Chair at the Institut Universitaire de France, and Guest Scientist at Institut Pasteur Paris (Malaria Parasite Biology and Vaccines Unit). His research focuses on antimalarial drug resistance, particularly the mechanisms underlying artemisinin resistance in Plasmodium falciparum. He led the discovery of K13 mutations as the molecular marker of artemisinin resistance (Nature 2014), subsequently validated through genetic confirmation (Science 2015) and global mapping (NEJM 2016). His work also demonstrated P. vivax infections in Duffy-negative African populations, challenging a long-held paradigm. With over 25 years of field experience across Africa and Southeast Asia within the Institut Pasteur International Network, he currently coordinates several international projects including IMPRIMA (EDCTP3). He serves on the WHO Technical Expert Group on Drug Efficacy and Response. His work has resulted in 289 publications (h-index 53) and multiple awards including the ASTMH Distinguished International Fellow and the Joseph Augustin Medal.

Organizations

Career arc: 1987 - 2026

Source: PubMed

Institut Pasteur

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 423

Citations

Citations: 20 662 1st author: 55 Last author: 137 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Genomic profiling of drug resistance markers in Plasmodium falciparum samples from the Democratic Republic of the Congo (2017) and Tanzania (2020-2021).
PMID 42678034 — pharmaceutical preparations, drug therapy, haplotypes, therapeutics, drug resistance
J Antimicrob Chemother20260
Clinical, molecular, and in vitro evidence of artemisinin partial resistance in Ethiopian Plasmodium falciparum: a prospective, multisite, surveillance study.
PMID 42551453 — malaria, malaria, falciparum, aged, microscopy, lumefantrine, prevalence, artemether, parasites, therapeutics, communicable diseases, seasons, mutation
Lancet Infect Dis Top journal20262
Comparative evaluation of four immunoassays for Plasmodium vivax serological detection using recombinant PvMSP1-42 antigen.
PMID 42555573 — malaria, enzyme-linked immunosorbent assay, immunoassay
PLoS Negl Trop Dis20260
Benchmarking of real-time, field-deployable whole-genome sequencing of Plasmodium falciparum using Nanopore technology.
PMID 42525447 — malaria, genomics, whole genome sequencing, genome, parasites, benchmarking, infections, nanopores, drug resistance
Microb Genom20260
Submicroscopic malaria infections and inadequate IPTp-SP coverage among pregnant women in rural Burkina Faso: An observational study.
PMID 42259058 — pregnant women, malaria, pregnancy, parturition, microscopy, prevalence, communicable diseases, infections
J Infect Public Health20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 4
Phase 4 2
Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 8

By type:

Interventional 6
Observational 2

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 2
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map